RGEN

REPLIGEN CORP

Healthcare | Mid Cap

$0.44

EPS Forecast

$193.7

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-08-16
DNLIDenali Therapeutics IncNVAXNovavax IncNBIXNeurocrine Biosciences IncTECHBio-techne CorpCRSPCrispr Therapeutics AgMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group Inc